<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003741'>Congenital muscular dystrophies</z:hpo> (CMDs) are defined by signs of <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> in the first 6 months of life with <z:hpo ids='HP_0003198'>myopathic changes</z:hpo> in muscle biopsy </plain></SENT>
<SENT sid="1" pm="."><plain>The progress in the last decade has helped to make molecular and genetic diagnoses in the majority of patients fulfilling these criteria </plain></SENT>
<SENT sid="2" pm="."><plain>In a number of patients a definite diagnosis cannot be reached and these individuals are often grouped together as "merosin positive" <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In the last 5 years, 25 patients referred for assessment as possible <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> have been found to have alternative diagnoses </plain></SENT>
<SENT sid="4" pm="."><plain>This paper aims to highlight these conditions as the common differentials or more difficult to diagnoses to consider in patients presenting as CMD </plain></SENT>
</text></document>